Skip to main content
. 2024 May 1;14(5):e077576. doi: 10.1136/bmjopen-2023-077576

Table 2.

Baseline characteristics of patients with cirrhosis according to the aetiology

Alcohol (I) Viral (II) NAFLD (III) P value
Total number of patients, n (%) 33 (19.2) 79 (45.9) 60 (34.9) /
Age, median (IQR) 65 (56–79) 81 (77–85) 78 (65–82) <0.001
0.007 (II vs III)
<0.001 (II vs I)
0.005 (III vs I)
Sex, n (%) 0.008
 Male 25 (75.8) 37 (46.8) 27 (45.0)
 Female 8 (24.2) 42 (53.2) 33 (55.0)
CIRS Comorbidity Index, median (IQR) 4.0 (3.0–5.0) 4.0 (3.0–5.0) 4.0 (3.0–6.0) 0.314
CIRS Severity Index, median (IQR) 1.85 (1.62–1.92) 1.85 (1.62–2.0) 1.85 (1.69–2.15) 0.423
Co-multimorbidity, n (%) 0.015
 Comorbidity 13 (39.4) 15 (19.0) 8 (13.3)
 Multimorbidity 20 (60.6) 64 (81.0) 52 (86.7)
BMI, median (IQR) 23.4 (21.5–29.4) 23.5 (20.5–26.6) 27.1 (23.7–31.8) <0.001
<0.001 (II vs III)
0.11 (II vs I)
0.02 (III vs I)
Edmonton Frail Scale >5, n (%) 0.604
 No 11 (33.3) 20 (25.3) 19 (31.7)
 Yes 22 (66.7) 59 (74.7) 41 (68.3)
Barthel index <60 0.164
 No 29 (87.9) 57 (72.1) 48 (80)
 Yes 4 (12.1) 22 (27.9) 12 (20)
Income <€1000/month, n (%) 0.523
 No 14 (42.4) 43 (54.4) 32 (53.3)
 Yes 19 (57.6) 36 (45.6) 28 (46.7)
Living alone, n (%) 0.219
 No 26 (78.8) 59 (74.7) 52 (86.7)
 Yes 7 (21.2) 20 (25.3) 8 (13.3)
Schooling <8 years, n (%) 0.282
 No 12 (36.4) 28 (35.4) 29 (48.3)
 Yes 21 (63.6) 51 (64.6) 31 (51.7)
Short blessed test >9, n (%) 0.102
 No 20 (60.6) 31 (39.7) 31 (51.7)
 Yes 13 (39.4) 47 (60.3) 29 (48.3)
Length of stay, median (IQR) 12.0 (8.0–19.0) 14.0 (9.0–19.0) 14.0 (10.0–21.5) 0.423

BMI, body mass index; CIRS, Cumulative Illness Rating Scale; NAFLD, non-alcoholic fatty liver disease.